Medical imaging equipment companies share some underlying policy goals with the broader medtech sector. But the realities of capital equipment intended primarily for diagnostic or screening applications also raise special considerations. We spoke to Patrick Hope, executive director of the Medical Imaging and Technology Alliance about the recently inked FDA user fee agreement, MITA’s legislative priorities for equipment servicing and cybersecurity, and the perspective of the imaging industry after two years in the pandemic.
Read more about the topics discussed:
• 7 User Fee Riders to Watch: From Cybersecurity to Remanufacturing to Payor Comms
https://bit.ly/3OogYFV
• FDA Tries to Draw a Line on What Constitutes Regulated Remanufacturing
https://bit.ly/3OntTrA
• FDA Targets Medtech Cybersecurity: An Interview with Kevin Fu, the First Device Cyber Czar
https://bit.ly/3xtDQ0k
View the latest issue of Market Pathways: https://bit.ly/3M4gsLc
View more podcast episodes: https://bit.ly/3vgFTlT
About Market Pathways
Your premium guide to global medical device regulation, reimbursement and policy. Market Pathways delivers incomparable intelligence exploring the people, challenges, and opportunities impacting the global medtech regulatory and reimbursement community. View the latest issue of Market Pathways on MyStrategist.com
